Development of an adverse outcome pathway network for breast cancer: a comprehensive representation of the pathogenesis, complexity and diversity of the disease.
- DOI
- 10.1007/s00204-022-03351-w
- Published
- 2022-08-04
- Container
- Arch Toxicol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00204-022-03351-w,
title = {Development of an adverse outcome pathway network for breast cancer: a comprehensive representation of the pathogenesis, complexity and diversity of the disease.},
author = {Del'haye GG and Nulmans I and Bouteille SP and Sermon K and Wellekens B and Rombaut M and Vanhaecke T and Vander Heyden Y and De Kock J.},
year = {2022},
journal = {Arch Toxicol},
doi = {10.1007/s00204-022-03351-w},
url = {https://doi.org/10.1007/s00204-022-03351-w}
}RIS
TY - JOUR TI - Development of an adverse outcome pathway network for breast cancer: a comprehensive representation of the pathogenesis, complexity and diversity of the disease. AU - Del'haye GG AU - Nulmans I AU - Bouteille SP AU - Sermon K AU - Wellekens B AU - Rombaut M AU - Vanhaecke T AU - Vander Heyden Y AU - De Kock J. PY - 2022 JO - Arch Toxicol DO - 10.1007/s00204-022-03351-w UR - https://doi.org/10.1007/s00204-022-03351-w ER -
APA
GG, D., I, N., SP, B., K, S., B, W., M, R., T, V., Y, V. H., & J., D. K. (2022). Development of an adverse outcome pathway network for breast cancer: a comprehensive representation of the pathogenesis, complexity and diversity of the disease.. Arch Toxicol. https://doi.org/10.1007/s00204-022-03351-w
Source records
- europe-pmc · retrieved 2026-09-27T11:47:58.940Z